Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2024

01-04-2024 | Autism Spectrum Disorder | Clinical study

Prenatal cannabis use increases risk of ADHD and autism in children

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Prenatal cannabis use in pregnant women with cannabis use disorder (CUD) increases the risk of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD) and intellectual disability (ID) in their children, according to findings of an Australian study presented at the European Psychiatric Association Congress 2024. …
Literature
Metadata
Title
Prenatal cannabis use increases risk of ADHD and autism in children
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56651-4

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Acetylcysteine/paracetamol

Case report

Amiodarone

Case report

Calcitriol/phosphorus

Case report

Heparin

Case report

Multiple drugs

Case report

Factor-VIII-inhibitor-bypassing-fraction/Recombinant-factor-VIIa